Stay updated on Palbociclib in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Palbociclib in Metastatic Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page shows a revision tag update from v3.4.2 to v3.4.3. The study content and page layout appear unchanged.SummaryDifference0.0%

- Check12 days agoChange DetectedThe Publications entry for the PALOMA-3 final analysis has been updated to include the Erratum and a 2016 July update, replacing the shorter citation with the expanded reference.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedResults posted on 2026-02-12 with expanded primary and secondary outcomes and time frames (PFS, OS, ORR, DOR, CBR). New documents and data sections were added, including the Study Protocol and Statistical Analysis Plan PDF, PK data, PIK3CA biomarker analyses, and tumor biomarker data.SummaryDifference0.9%

- Check34 days agoChange DetectedAdded a site revision tag 'Revision: v3.4.2' and removed older funding notices including 'Revision: v3.4.1' and the lapse-in-funding message. Core study content and navigation remain unchanged.SummaryDifference0.2%

- Check41 days agoChange DetectedA government funding lapse notice was added at the top of the page to inform users about possible delays and NIH operation status. The Publications section was updated with a new NEJM article citation on Palbociclib for HR+/HER2+ Advanced Breast Cancer, and the page revision tag updated to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary is now displayed, and the page includes new footer/version details: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Palbociclib in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.